These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 186848)

  • 1. [Research progress of secondary metabolites produced by microorganisms--enzyme inhibitors (author's transl)].
    Umezawa H
    Tanpakushitsu Kakusan Koso; 1976 Oct; 21(10):776-90. PubMed ID: 186848
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight enzyme inhibitors of microbial origin.
    Umezawa H
    Annu Rev Microbiol; 1982; 36():75-99. PubMed ID: 6293372
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compounds.
    Umezawa H
    Biomedicine; 1977 Jul; 26(4):236-49. PubMed ID: 72569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Some problems in finding and in the microbiological synthesis of physiologically active compounds].
    Bezborodov AM
    Antibiotiki; 1975 Oct; 20(10):948-56. PubMed ID: 1211893
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in bioactive microbial secondary metabolites.
    Umezawa H
    Jpn J Antibiot; 1977 Dec; 30 Suppl():138-63. PubMed ID: 77338
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of imipramine, nomifensine and d-amphetamine on type B monoamine oxidase, cyclic AMP phosphodiesterase and dopamine-beta-hydroxylase.
    Izumi H; Togashi O; Hayakari M; Hayashi S; Ozawa H
    Tohoku J Exp Med; 1976 Mar; 118(3):223-31. PubMed ID: 178070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous protein inhibitor of mitochondrial c-AMP phosphodiesterase in tumour bearing rats.
    Sankaran K
    Indian J Biochem Biophys; 1986 Apr; 23(2):66-9. PubMed ID: 3021610
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on bioactive compounds from microorganisms.
    Omura S; Oiwa R
    Kitasato Arch Exp Med; 1984 Jun; 57(2):75-204. PubMed ID: 6397654
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological study of 2-phosphonoxybenzoic acid (fosfosal), a new analgesic drug.
    Rafanell JG; Bellés L; Sánchez MS; Forn J
    Arzneimittelforschung; 1980; 30(7):1091-8. PubMed ID: 6251858
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioactive secondary metabolites from marine microbes for drug discovery.
    Nikapitiya C
    Adv Food Nutr Res; 2012; 65():363-87. PubMed ID: 22361200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors.
    Bourguignon JJ; Désaubry L; Raboisson P; Wermuth CG; Lugnier C
    J Med Chem; 1997 Jun; 40(12):1768-70. PubMed ID: 9191951
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
    Shchekoldina TG; Vatolkina OE; Libinzon RE
    Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new phytotoxic nonenolide from Phoma herbarum.
    Rivero-Cruz JF; Macías M; Cerda-García-Rojas CM; Mata R
    J Nat Prod; 2003 Apr; 66(4):511-4. PubMed ID: 12713403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern therapy of COPD].
    Pariente R; Aubier M
    Bull Acad Natl Med; 2004; 188(1):67-74; discussion 74-5. PubMed ID: 15368926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of serine protease inhibitors on morphological differentiation of murine neuroblastoma cells (NB15).
    Gibson WH; Burack SL; Picciano A
    J Cell Physiol; 1984 Apr; 119(1):119-26. PubMed ID: 6323488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The failing heart as a drug target: are we finally seeing progress?
    Mucke HA
    Curr Opin Investig Drugs; 2005 Sep; 6(9):870-3. PubMed ID: 16187685
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of purine inhibitors of phosphodiesterase 7 (PDE7).
    Pitts WJ; Vaccaro W; Huynh T; Leftheris K; Roberge JY; Barbosa J; Guo J; Brown B; Watson A; Donaldson K; Starling GC; Kiener PA; Poss MA; Dodd JH; Barrish JC
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2955-8. PubMed ID: 15125967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.
    Provins L; Christophe B; Danhaive P; Dulieu J; Durieu V; Gillard M; Lebon F; Lengelé S; Quéré L; van Keulen B
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1834-9. PubMed ID: 16439121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme inhibitors from algae.
    Lincoln RA; Strupinski K; Walker JM
    Biochem Soc Trans; 1991 Nov; 19(4):429S. PubMed ID: 1665441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.